活血化瘀中药熏蒸联合丹参注射液穴位注射治疗小儿过敏性紫癜临床研究

来源 :亚太传统医药 | 被引量 : 0次 | 上传用户:xiaoqingwa123456789
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的:观察活血化瘀中药熏蒸联合丹参注射液穴位注射治疗小儿过敏性紫癜的临床疗效。方法:将81例过敏性紫癜患儿随机分为对照组(n=40)与观察组(n=41),对照组患儿采用西医常规治疗,观察组患儿联合活血化瘀中药熏蒸及丹参注射液穴位注射,以21天为1个疗程。观察比较两组患者临床疗效及复发情况。结果:治疗后,观察组患儿腹痛、关节疼痛及紫癜等症状消失时间较对照组更早(P<0.05);观察组患儿治疗总有效率为95.12%,明显高于对照组的72.50%,且药物不良反应发生率较对照组低,差异具有统计学意义(P<0.05);持续随访1年,对照组患儿复发率为37.50%,高于观察组的14.63%,差异具有统计学意义(P<0.05)。结论:活血化瘀中药熏蒸联合丹参注射液穴位注射治疗小儿过敏性紫癜效果明显,可缩短病程,值得临床推广应用。 Objective: To observe the clinical efficacy of traditional Chinese medicine fumigation combined with Salvia miltiorrhiza injection acupoint injection in the treatment of children with Henoch-Schonlein purpura. Methods: Eighty-one children with Henoch-Schonlein purpura were randomly divided into control group (n = 40) and observation group (n = 41). Children in the control group were treated with conventional western medicine. Injection point injection to 21 days for a course of treatment. The clinical efficacy and recurrence of the two groups were observed and compared. Results: After treatment, the disappearance time of abdominal pain, joint pain and purpura in the observation group was earlier than that of the control group (P <0.05). The total effective rate in the observation group was 95.12%, significantly higher than that in the control group (72.50% , And the incidence of adverse drug reactions than the control group, the difference was statistically significant (P <0.05); sustained follow-up of 1 year, the control group recurrence rate was 37.50%, higher than the observation group 14.63%, the difference was statistically Significance (P <0.05). Conclusion: The Chinese medicine fumigation combined with injection of Salvia miltiorrhiza injection acupuncture point injection treatment of children with Henoch-Schonlein purpura obvious effect, can shorten the course of disease, worthy of clinical promotion and application.
其他文献
世界卫生组织规定14~44岁为青年期,该年龄段发生的脑卒中称为青年脑卒中.近年来,青年脑卒中发病率逐渐增高.青年急性缺血性脑卒中为青年脑卒中的常见类型,其病死率、致残率均较高.大量研究结果已证实,丁苯酞具有明显的、独特的抗急性脑缺血、改善脑血管微循环的作用[1-2].我院应用丁苯酞软胶囊治疗青年急性缺血性脑卒中,取得较好的疗效,现报道如下。